4//SEC Filing
SIGAL ELLIOT 4
Accession 0001609351-18-000028
CIK 0001609351other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 5:49 PM ET
Size
6.2 KB
Accession
0001609351-18-000028
Insider Transaction Report
Form 4
SIGAL ELLIOT
Director
Transactions
- Purchase
Common Stock
2017-10-12$90.75/sh+29$2,632→ 11,243 total - Sale
Common Stock
2017-11-28$72.43/sh−29$2,100→ 11,214 total
Footnotes (1)
- [F1]Reflects transactions occurring in a brokerage account managed by an investment advisor who maintained discretionary authority over the account. The transactions were made by the investment advisor in contradiction of the Reporting Person's instructions and without the Reporting Person's approval.
Documents
Issuer
Spark Therapeutics, Inc.
CIK 0001609351
Entity typeother
Related Parties
1- filerCIK 0001202294
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 5:49 PM ET
- Size
- 6.2 KB